HELX Franklin Genomic Advancements ETF

NAV as of 13-May-2022

31.7900

4 Week: 30.12 - 35.43

52 Week: 30.12 - 58.23

Latest Closing Price

31.78

Premium / Discount

-0.18

Expense Ratio

0.5%

Investment Objective

The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Main Fund Characteristics

Fund Manager:
Franklin Templeton Investments
Asset Under Management:
14,314,001
Launch Date:
24/02/2020
Asset Class:
Equity
Replication Method:
Not Applicable
Number of Holdings:
52
Trading Currency:
USD
Style:
Large Growth
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
CBOEBZX

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-34.482.20-15.67
1 Day3.960.000.00
1 Week-0.818.22-0.10
1 Month-11.6411.84-0.98
3 Months-16.9217.43-0.97
6 Months-36.8323.27-1.58
1 Year-20.1829.82-0.68
2 Years12.5643.940.29
3 Years0.000.000.00
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00009.6606
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.00000.00000.000056.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
29/12/202106/01/20220.0039
12/12/202120/12/20210.1142
13/12/202022/12/20200.0050

Portfolio Data

Total Number of Holdings: 52

Number of Bond Holdings: 0

Number of Equity Holdings: 51

Total Market Value: 14,314,001

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Thermo Fisher Scientific Inc6.74791,7840965,893

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant22.61
Large26.54
Medium36.47
Small7.85
Micro3.76

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

22.7248

Price/Book*

2.9253

Price/Sales*

2.6345

Price/Cash Flow*

12.7286

Dividend Yield*

0.5265

Growth Measures

Long-Term Earnings

15.6121

Historical Earnings

39.3883

Sales Growth

20.0599

Cash-Flow Growth

44.0149

Book-Value Growth

30.5067

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.